{"id":"https://openalex.org/W3006175129","doi":"https://doi.org/10.1158/1538-7445.sabcs19-p6-10-08","title":"Abstract P6-10-08: AKT1 alterations following exposure to endocrine-based therapy in patients with hormone-receptor positive (HR+) metastatic breast cancer (MBC): Clinical and functional implications","display_name":"Abstract P6-10-08: AKT1 alterations following exposure to endocrine-based therapy in patients with hormone-receptor positive (HR+) metastatic breast cancer (MBC): Clinical and functional implications","publication_year":2020,"publication_date":"2020-02-15","ids":{"openalex":"https://openalex.org/W3006175129","doi":"https://doi.org/10.1158/1538-7445.sabcs19-p6-10-08","mag":"3006175129"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs19-p6-10-08","doi":"https://doi.org/10.1158/1538-7445.sabcs19-p6-10-08","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs19-p6-10-08","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025351031","display_name":"Seth Andrew Wander","orcid":"https://orcid.org/0000-0002-4127-4708","observed_orcids":["https://orcid.org/0000-0002-4127-4708"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Seth Wander","raw_affiliation_strings":["1Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011630205","display_name":"Pingping Mao","orcid":"https://orcid.org/0009-0002-6608-6559","observed_orcids":["https://orcid.org/0009-0002-6608-6559"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pingping Mao","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064753594","display_name":"Maxwell Roger Lloyd","orcid":"https://orcid.org/0000-0001-9810-0437","observed_orcids":["https://orcid.org/0000-0001-9810-0437"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maxwell Lloyd","raw_affiliation_strings":["1Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020013190","display_name":"Kailey J. Kowalski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kailey Kowalski","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055952938","display_name":"Gabriela N. Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriela N. Johnson","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087584954","display_name":"Giuliana Malvarosa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Giuliana Malvarosa","raw_affiliation_strings":["1Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017550097","display_name":"Beverly Moy","orcid":"https://orcid.org/0000-0003-3472-1140","observed_orcids":["https://orcid.org/0000-0003-3472-1140"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Beverly Moy","raw_affiliation_strings":["1Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052735318","display_name":"Leif William Ellisen","orcid":"https://orcid.org/0000-0003-0444-7910","observed_orcids":["https://orcid.org/0000-0003-0444-7910"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leif W. Ellisen","raw_affiliation_strings":["1Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020535260","display_name":"John Iafrate","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Iafrate","raw_affiliation_strings":["1Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068721624","display_name":"Nikhil Wagle","orcid":"https://orcid.org/0000-0003-3332-9438","observed_orcids":["https://orcid.org/0000-0003-3332-9438"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil Wagle","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034972183","display_name":"Aditya Bardia","orcid":"https://orcid.org/0000-0003-4885-1157","observed_orcids":["https://orcid.org/0000-0003-4885-1157"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aditya Bardia","raw_affiliation_strings":["1Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"4_Supplement","first_page":"P6","last_page":"10"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.8988999724388123,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.8988999724388123,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.09160000085830688,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/akt1-mutation","display_name":"AKT1 mutation","score":0.9100000262260437},{"id":"https://openalex.org/keywords/hormone-receptor-positive-metastatic-breast-cancer","display_name":"hormone receptor-positive metastatic breast cancer","score":0.7839999794960022},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.7559999823570251},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9490000009536743},{"id":"https://openalex.org/keywords/pik3ca","display_name":"PIK3CA","score":0.7870000004768372},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.8149999976158142},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.675000011920929},{"id":"https://openalex.org/keywords/cell-free-dna","display_name":"cell-free DNA","score":0.6309999823570251},{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.7929999828338623},{"id":"https://openalex.org/keywords/fulvestrant","display_name":"fulvestrant","score":0.8450000286102295},{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.9940000176429749},{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":0.8009999990463257},{"id":"https://openalex.org/keywords/esr1","display_name":"ESR1","score":0.5289999842643738},{"id":"https://openalex.org/keywords/tp53","display_name":"TP53","score":0.7179999947547913},{"id":"https://openalex.org/keywords/rb1","display_name":"RB1","score":0.5109999775886536}],"concepts":[{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.8540511131286621},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6557397842407227},{"id":"https://openalex.org/C154137905","wikidata":"https://www.wikidata.org/wiki/Q17816452","display_name":"AKT1","level":4,"score":0.6505838632583618},{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.5677236318588257},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5188149809837341},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4809500575065613},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4675307273864746},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.46594488620758057},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4597734212875366},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.45653969049453735},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4458004832267761},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.3940392732620239},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20265716314315796},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.18223586678504944},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08824855089187622}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs19-p6-10-08","doi":"https://doi.org/10.1158/1538-7445.sabcs19-p6-10-08","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs19-p6-10-08","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3092444353","https://openalex.org/W7035962836","https://openalex.org/W2605250053","https://openalex.org/W2048131754","https://openalex.org/W2767035762","https://openalex.org/W2885972791","https://openalex.org/W7172191302","https://openalex.org/W4220954223","https://openalex.org/W2090631044","https://openalex.org/W4310249343"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"The":[2],"AKT1":[3,45,72,137,167,183,186,243,262,287,312,341,374,418,427,454,483],"oncogene":[4],"represents":[5],"a":[6,132,174,231,356,363],"central":[7],"node":[8],"in":[9,17,153,192,222,313,384,395,408,490],"the":[10,18,29,42,47,91,117,129,223,239,258,308,323,370,414,426,508],"well-characterized":[11],"PI3K/AKT/mTOR":[12],"signal":[13],"transduction":[14],"pathway":[15],"involved":[16],"regulation":[19],"of":[20,31,44,49,71,131,143,212,241,246,260,275,311,339,382,416,507],"cellular":[21],"proliferation":[22],"as":[23,25,273],"well":[24],"therapeutic":[26,447],"resistance.":[27],"With":[28],"emergence":[30],"multiple":[32,433],"targeted":[33,380,405],"therapies":[34],"for":[35,450],"HR+":[36],"MBC,":[37,161,388],"we":[38,162],"sought":[39],"to":[40,58,107,135,140,209,215,230,235,267,270,317,332,351,398,410,423,440,487],"explore":[41],"prevalence":[43],"alterations,":[46],"spectrum":[48],"co-occurring":[50],"mutations,":[51],"and":[52,64,145,201,289,294,300,320,335,349,389,402,444,501],"any":[53],"potential":[54,309],"impact":[55],"on":[56,250,292],"response":[57,350,409],"endocrine-based":[59,411,488],"therapy,":[60],"including":[61],"CDK":[62],"4/6":[63],"PIK3CA":[65,195,364],"inhibitors.":[66],"Methods:":[67],"Presence":[68],"or":[69,430],"absence":[70],"mutation":[73,168,288],"was":[74,264],"interrogated":[75,148],"via":[76,149,218,379],"cell-free":[77],"DNA":[78],"(cfDNA)":[79],"analysis":[80],"(Guardant":[81],"assay)":[82],"among":[83],"patients":[84,158,165,172,205,348,385,451,491],"with":[85,126,159,166,190,285,298,346,386,452,492],"HR+/HER2-":[86,119,160,326,387,453],"MBC":[87],"receiving":[88],"treatment":[89,297],"at":[90,369],"Massachusetts":[92],"General":[93],"Hospital":[94],"who":[95],"underwent":[96],"routine":[97],"clinical":[98,109,248,276,305,315,344],"cfDNA":[99,236,383],"testing.":[100],"Genomic":[101],"sequencing":[102,381,448],"results":[103],"were":[104,124,147,255,278],"then":[105],"compared":[106],"detailed":[108],"annotation":[110],"based":[111],"upon":[112],"retrospective":[113],"chart":[114],"review.":[115],"In":[116,281,322],"laboratory,":[118],"T47D":[120],"breast":[121,327,497],"cancer":[122,328,498],"cells":[123,329],"transfected":[125],"AKT1,":[127],"under":[128],"control":[130],"doxycycline-inducible":[133],"promoter,":[134],"induce":[136],"overexpression.":[138],"Sensitivity":[139],"escalating":[141],"doses":[142],"fulvestrant":[144,299,334],"palbociclib":[146,336],"cell-titer-glo":[150],"viability":[151],"assay":[152],"vitro.":[154],"Results:":[155],"Among":[156],"272":[157],"identified":[163,378],"13":[164],"(4.7%).":[169],"12/13":[170],"(92%)":[171],"had":[173,181,206,228],"canonical":[175],"AKT1E17K":[176],"alteration,":[177,244],"one":[178],"patient":[179,284],"(8%)":[180],"an":[182,242,261,282,286,354,359,392,417],"E49K":[184],"alteration.":[185],"mutations":[187,375],"occurred":[188],"concurrently":[189],"alterations":[191,484],"ESR1":[193],"(31%),":[194],"(23%),":[196,198],"TP53":[197],"ERBB2":[199],"(15%),":[200],"RB1":[202],"(8%).":[203],"All":[204],"been":[207],"exposed":[208],"some":[210],"form":[211],"anti-estrogen":[213],"prior":[214,234,290],"sequencing,":[216],"either":[217],"(neo)adjuvant":[219],"therapy":[220,319,412,489],"and/or":[221,253,362],"metastatic":[224,496],"setting;":[225],"5/13":[226],"(38%)":[227],"exposure":[229,486],"CDK4/6":[232,357,400],"inhibitor":[233,365],"sequencing.":[237],"Following":[238],"identification":[240,415],"examples":[245],"rapid":[247],"progression":[249,291],"fulvestrant,":[251],"CDK4/6i,":[252],"everolimus":[254],"identified,":[256],"however":[257],"presence":[259],"alteration":[263,419],"not":[265,303],"sufficient":[266],"predict":[268],"pan-resistance":[269],"these":[271,442],"agents,":[272],"counter-examples":[274],"benefit":[277],"also":[279],"identified.":[280],"index":[283],"letrozole":[293],"palbociclib,":[295],"subsequent":[296],"abemaciclib":[301],"did":[302],"yield":[304],"benefit,":[306],"highlighting":[307],"role":[310,394],"mediating":[314,396],"resistance":[316,331,397,434],"endocrine":[318],"CDK4/6i.":[321],"pre-clinical":[324],"model,":[325],"demonstrated":[330],"both":[333],"following":[337,413,485],"upregulation":[338],"exogenous":[340],"expression.":[342],"Updated":[343],"data":[345],"additional":[347],"regimens":[352],"incorporating":[353],"anti-estrogen,":[355],"inhibitor,":[358,361],"mTOR":[360],"will":[366],"be":[367,377,421],"presented":[368],"meeting.":[371],"Conclusions:":[372],"Activating":[373],"can":[376],"may":[390,420],"play":[391],"important":[393],"anti-estrogens,":[399],"inhibitors,":[401],"other":[403],"emerging":[404],"therapies.":[406],"Heterogeneity":[407],"related":[422],"tumor-extrinsic":[424],"factors,":[425],"allelic":[428],"fraction,":[429],"cooperativity":[431],"between":[432],"drivers.":[435],"Further":[436],"research":[437],"is":[438],"needed":[439],"confirm":[441],"findings":[443],"guide":[445],"optimal":[446],"strategies":[449],"mutant":[455],"MBC.":[456],"Citation":[457],"Format:":[458],"Seth":[459],"Wander,":[460],"Pingping":[461],"Mao,":[462],"Maxwell":[463],"Lloyd,":[464],"Kailey":[465],"Kowalski,":[466],"Gabriela":[467],"N.":[468],"Johnson,":[469],"Giuliana":[470],"Malvarosa,":[471],"Beverly":[472],"Moy,":[473],"Leif":[474],"W.":[475],"Ellisen,":[476],"John":[477],"Iafrate,":[478],"Nikhil":[479],"Wagle,":[480],"Aditya":[481],"Bardia.":[482],"hormone-receptor":[493],"positive":[494],"(HR+)":[495],"(MBC):":[499],"Clinical":[500],"functional":[502],"implications":[503],"[abstract].":[504],"In:":[505],"Proceedings":[506],"2019":[509,515],"San":[510,518],"Antonio":[511],"Breast":[512],"Cancer":[513,524],"Symposium;":[514],"Dec":[516],"10-14;":[517],"Antonio,":[519],"TX.":[520],"Philadelphia":[521],"(PA):":[522],"AACR;":[523],"Res":[525],"2020;80(4":[526],"Suppl):Abstract":[527],"nr":[528],"P6-10-08.":[529]},"counts_by_year":[],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2020-02-24T00:00:00"}